Relapse rates in an early psychosis treatment service

被引:23
作者
Addington, D.
Addington, M. D. Jean
Patten, S.
机构
[1] Univ Calgary, Dept Psychiat, Calgary, AB T2N 1N4, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M4X 1K9, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada
关键词
schizophrenia; schizoaffective disorder; early psychosis treatment services; treatment outcome; relapse; FIRST-EPISODE SCHIZOPHRENIA; EARLY INTERVENTION; FOLLOW-UP; UNTREATED PSYCHOSIS; NATURAL COURSE; 1ST EPISODE; PREDICTORS; HALOPERIDOL; RISPERIDONE; DISORDERS;
D O I
10.1111/j.1600-0447.2006.00879.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To examine the relapse rate achievable in a real-life early psychosis treatment service. Method: A 2-year longitudinal cohort study of consecutive admissions to an early psychosis programme which served the entire population in a catchment area. The primary outcome measure was relapse. Results: One hundred and forty-eight consecutive consenting admissions were recruited, 124 (83.8%) of whom were followed for 1 year and 116 (78.4%) for 2 years. Relapse was assessed by clinicians using structured criteria. The 2-year relapse rate among subjects with complete data collection was 34/95 (35.7%, 95% CI 26.2-46.3). A Kaplan-Meier life table censoring subjects lost to follow-up yielded a comparable estimate of the proportion not relapsing: 68% (95% CI 58-76%). Conclusion: These estimates compare favourably with a published range of 2-year relapse from 55% to 70% in the older literature and are comparable with the results in recent clinical trials.
引用
收藏
页码:126 / 131
页数:6
相关论文
共 36 条
[1]   Performance measures for early psychosis treatment services [J].
Addington, D ;
McKenzie, E ;
Addington, J ;
Patten, S ;
Smith, H ;
Adair, C .
PSYCHIATRIC SERVICES, 2005, 56 (12) :1570-1582
[2]   The role of family work in early psychosis [J].
Addington, J ;
Collins, A ;
McCleery, A ;
Addington, D .
SCHIZOPHRENIA RESEARCH, 2005, 79 (01) :77-83
[3]  
Addington J., 2001, Canadian Psychiatric Association Bulletin, V33, P11
[4]  
*AG HEALTHC RES QU, 2005, SYST RAT STRENGTH SC, V47, P1
[5]   Relapse in schizophrenia: costs, clinical outcomes and quality of life [J].
Almond, S ;
Knapp, M ;
Francois, C ;
Toumi, M ;
Brugha, T .
BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 :346-351
[6]  
[Anonymous], 2004, British Medical Journal, DOI DOI 10.1136/bmj.329.7456.1
[7]   Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies [J].
Correll, CU ;
Leucht, S ;
Kane, JM .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03) :414-425
[8]   Pattern of health service utilization and predictors of readmission after a first admission for psychosis: a 2-year follow-up study [J].
Cougnard, A ;
Parrot, M ;
Grolleau, S ;
Kalmi, E ;
Desage, A ;
Misdrahi, D ;
Brun-Rousseau, H ;
Verdoux, H .
ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 (04) :340-349
[9]   Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? [J].
Craig, TJ ;
Bromet, EJ ;
Fennig, S ;
Tanenberg-Karant, M ;
Lavelle, J ;
Galambos, N .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :60-66
[10]   A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia [J].
Csernansky, JG ;
Mahmoud, R ;
Brenner, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01) :16-22